Baidu
map

PLoS One:精浆增强子宫颈癌细胞增殖以及肿瘤生长

2012-04-10 Deepblue 生物谷

在撒哈拉南部非洲,宫颈癌是一种主要引起妇女死因的癌症。广泛的证据表明,宫颈癌及其癌前病变是由人乳头瘤病毒(HPV)的感染引起。虽然绝大多数的HPV的感染是自然感染的,根除感染细胞的失败被表明会促进病毒存留以及肿瘤发生。 紧跟着致瘤性转化,通过直接或者是体循环的方式暴露在炎症因子中时,可能会增强宫颈上皮细胞疾病的发展。总所周知,精浆(SP) 包含了大量的炎症介质,它们都被鉴定为肿瘤生长有关的调节因

在撒哈拉南部非洲,宫颈癌是一种主要引起妇女死因的癌症。广泛的证据表明,宫颈癌及其癌前病变是由人乳头瘤病毒(HPV)的感染引起。虽然绝大多数的HPV的感染是自然感染的,根除感染细胞的失败被表明会促进病毒存留以及肿瘤发生。

紧跟着致瘤性转化,通过直接或者是体循环的方式暴露在炎症因子中时,可能会增强宫颈上皮细胞疾病的发展。总所周知,精浆(SP) 包含了大量的炎症介质,它们都被鉴定为肿瘤生长有关的调节因子。近日,来自南非开普顿大学的Arieh A. Katz等人研究了开展了一项有意义的研究,即研究精浆在调节宫颈上皮细胞生长和肿瘤发生中的作用。研究发现,精浆可以明显增强子宫颈癌细胞增殖以及肿瘤生长。相关研究发表在3月19号美国《公共科学图书馆·综合》(PLoS One)上。

本次研究Arieh A. Katz利用了海拉细宫颈癌细胞,结果发现精浆(SP)引起了细胞内炎性酶,前列腺素内过氧化物合酶(PTGS1和PTGS2),IL-1及IL-11,血管内皮生长因子A(VEGF-A)的表达。为了研究在活体内精浆对肿瘤细胞生长的作用,他们异种移植海拉细胞于裸鼠的背部侧面皮下。研究发现,SP可以快速而明显的提高肿瘤生长率以及增大海拉细胞在裸鼠中的大小。检测发现,SP引起了体内的PTGS酶,细胞因子以及VEGF-A的表达。进一步研究发现,SP增大了这些裸鼠的血管。

结果表明,精浆确实增强子宫颈癌细胞增殖以及肿瘤生长。另外,SP引起的细胞因子的产生,VEGF-A的表达以及细胞增殖被PTGS通路所调节。(生物谷Deepblue编译)

doi: 10.1371/journal.pone.0033848
PMC:
PMID:

Seminal Plasma Enhances Cervical Adenocarcinoma Cell Proliferation and Tumour Growth In Vivo

Jason R. Sutherland, Kurt J. Sales, Henry N. Jabbour, Arieh A. Katzl.

Cervical cancer is one of the leading causes of cancer-related death in women in sub-Saharan Africa. Extensive evidence has shown that cervical cancer and its precursor lesions are caused by Human papillomavirus (HPV) infection. Although the vast majority of HPV infections are naturally resolved, failure to eradicate infected cells has been shown to promote viral persistence and tumorigenesis.Furthermore, following neoplastic transformation, exposure of cervical epithelial cells to inflammatory mediators either directly or via the systemic circulation may enhance progression of the disease. It is well recognised that seminal plasma contains an abundance of inflammatory mediators, which are identified as regulators of tumour growth. Here we investigated the role of seminal plasma in regulating neoplastic cervical epithelial cell growth and tumorigenesis.Using HeLa cervical adenocarcinoma cells, we found that seminal plasma (SP) induced the expression of the inflammatory enzymes, prostaglandin endoperoxide synthase (PTGS1 and PTGS2), cytokines interleukin (IL) -6, and -11 and vascular endothelial growth factor-A(VEGF-A). To investigate the role of SP on tumour cell growth in vivo, we xenografted HeLa cells subcutaneously into the dorsal flank of nude mice.Intra-peritoneal administration of SP rapidly and significantly enhanced the tumour growth rate and size of HeLa cell xenografts in nude mice. As observed in vitro, we found that SP induced expression of inflammatory PTGS enzymes, cytokines and VEGF-A in vivo. Furthermore we found that SP enhances blood vessel size in HeLa cell xenografts. Finally we show that SP-induced cytokine production, VEGF-A expression and cell proliferation are mediated via the induction of the inflammatory PTGS pathway.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1967350, encodeId=8bbc196e35042, content=<a href='/topic/show?id=56094228264' target=_blank style='color:#2F92EE;'>#增强子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42282, encryptionId=56094228264, topicName=增强子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Mar 01 02:45:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006679, encodeId=7d0920066e902, content=<a href='/topic/show?id=199d452095f' target=_blank style='color:#2F92EE;'>#子宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45209, encryptionId=199d452095f, topicName=子宫颈)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKjqGDO7icVKUiaT7urgwXvnvzWtp0fMFU46Xfib8oavFKygiaWtibXReS6ZUh3PImsNicGAwTO5HXxoicnA/132, createdBy=ee262500130, createdName=ms7474195563676018, createdTime=Mon Apr 30 06:45:00 CST 2012, time=2012-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789396, encodeId=08af1e89396c0, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Oct 01 23:45:00 CST 2012, time=2012-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701014, encodeId=1e2f1e010148b, content=<a href='/topic/show?id=7113e15237a' target=_blank style='color:#2F92EE;'>#癌细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71523, encryptionId=7113e15237a, topicName=癌细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb930318282, createdName=hywen7336, createdTime=Sat Jan 19 09:45:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251865, encodeId=31231251865d0, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282855, encodeId=404d1282855ed, content=<a href='/topic/show?id=53f24521227' target=_blank style='color:#2F92EE;'>#子宫颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45212, encryptionId=53f24521227, topicName=子宫颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407883, encodeId=b6ac140e883e9, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540857, encodeId=fd3c154085e10, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2013-03-01 tulenzi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1967350, encodeId=8bbc196e35042, content=<a href='/topic/show?id=56094228264' target=_blank style='color:#2F92EE;'>#增强子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42282, encryptionId=56094228264, topicName=增强子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Mar 01 02:45:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006679, encodeId=7d0920066e902, content=<a href='/topic/show?id=199d452095f' target=_blank style='color:#2F92EE;'>#子宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45209, encryptionId=199d452095f, topicName=子宫颈)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKjqGDO7icVKUiaT7urgwXvnvzWtp0fMFU46Xfib8oavFKygiaWtibXReS6ZUh3PImsNicGAwTO5HXxoicnA/132, createdBy=ee262500130, createdName=ms7474195563676018, createdTime=Mon Apr 30 06:45:00 CST 2012, time=2012-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789396, encodeId=08af1e89396c0, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Oct 01 23:45:00 CST 2012, time=2012-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701014, encodeId=1e2f1e010148b, content=<a href='/topic/show?id=7113e15237a' target=_blank style='color:#2F92EE;'>#癌细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71523, encryptionId=7113e15237a, topicName=癌细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb930318282, createdName=hywen7336, createdTime=Sat Jan 19 09:45:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251865, encodeId=31231251865d0, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282855, encodeId=404d1282855ed, content=<a href='/topic/show?id=53f24521227' target=_blank style='color:#2F92EE;'>#子宫颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45212, encryptionId=53f24521227, topicName=子宫颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407883, encodeId=b6ac140e883e9, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540857, encodeId=fd3c154085e10, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1967350, encodeId=8bbc196e35042, content=<a href='/topic/show?id=56094228264' target=_blank style='color:#2F92EE;'>#增强子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42282, encryptionId=56094228264, topicName=增强子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Mar 01 02:45:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006679, encodeId=7d0920066e902, content=<a href='/topic/show?id=199d452095f' target=_blank style='color:#2F92EE;'>#子宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45209, encryptionId=199d452095f, topicName=子宫颈)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKjqGDO7icVKUiaT7urgwXvnvzWtp0fMFU46Xfib8oavFKygiaWtibXReS6ZUh3PImsNicGAwTO5HXxoicnA/132, createdBy=ee262500130, createdName=ms7474195563676018, createdTime=Mon Apr 30 06:45:00 CST 2012, time=2012-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789396, encodeId=08af1e89396c0, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Oct 01 23:45:00 CST 2012, time=2012-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701014, encodeId=1e2f1e010148b, content=<a href='/topic/show?id=7113e15237a' target=_blank style='color:#2F92EE;'>#癌细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71523, encryptionId=7113e15237a, topicName=癌细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb930318282, createdName=hywen7336, createdTime=Sat Jan 19 09:45:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251865, encodeId=31231251865d0, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282855, encodeId=404d1282855ed, content=<a href='/topic/show?id=53f24521227' target=_blank style='color:#2F92EE;'>#子宫颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45212, encryptionId=53f24521227, topicName=子宫颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407883, encodeId=b6ac140e883e9, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540857, encodeId=fd3c154085e10, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1967350, encodeId=8bbc196e35042, content=<a href='/topic/show?id=56094228264' target=_blank style='color:#2F92EE;'>#增强子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42282, encryptionId=56094228264, topicName=增强子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Mar 01 02:45:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006679, encodeId=7d0920066e902, content=<a href='/topic/show?id=199d452095f' target=_blank style='color:#2F92EE;'>#子宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45209, encryptionId=199d452095f, topicName=子宫颈)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKjqGDO7icVKUiaT7urgwXvnvzWtp0fMFU46Xfib8oavFKygiaWtibXReS6ZUh3PImsNicGAwTO5HXxoicnA/132, createdBy=ee262500130, createdName=ms7474195563676018, createdTime=Mon Apr 30 06:45:00 CST 2012, time=2012-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789396, encodeId=08af1e89396c0, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Oct 01 23:45:00 CST 2012, time=2012-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701014, encodeId=1e2f1e010148b, content=<a href='/topic/show?id=7113e15237a' target=_blank style='color:#2F92EE;'>#癌细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71523, encryptionId=7113e15237a, topicName=癌细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb930318282, createdName=hywen7336, createdTime=Sat Jan 19 09:45:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251865, encodeId=31231251865d0, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282855, encodeId=404d1282855ed, content=<a href='/topic/show?id=53f24521227' target=_blank style='color:#2F92EE;'>#子宫颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45212, encryptionId=53f24521227, topicName=子宫颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407883, encodeId=b6ac140e883e9, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540857, encodeId=fd3c154085e10, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1967350, encodeId=8bbc196e35042, content=<a href='/topic/show?id=56094228264' target=_blank style='color:#2F92EE;'>#增强子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42282, encryptionId=56094228264, topicName=增强子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Mar 01 02:45:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006679, encodeId=7d0920066e902, content=<a href='/topic/show?id=199d452095f' target=_blank style='color:#2F92EE;'>#子宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45209, encryptionId=199d452095f, topicName=子宫颈)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKjqGDO7icVKUiaT7urgwXvnvzWtp0fMFU46Xfib8oavFKygiaWtibXReS6ZUh3PImsNicGAwTO5HXxoicnA/132, createdBy=ee262500130, createdName=ms7474195563676018, createdTime=Mon Apr 30 06:45:00 CST 2012, time=2012-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789396, encodeId=08af1e89396c0, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Oct 01 23:45:00 CST 2012, time=2012-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701014, encodeId=1e2f1e010148b, content=<a href='/topic/show?id=7113e15237a' target=_blank style='color:#2F92EE;'>#癌细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71523, encryptionId=7113e15237a, topicName=癌细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb930318282, createdName=hywen7336, createdTime=Sat Jan 19 09:45:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251865, encodeId=31231251865d0, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282855, encodeId=404d1282855ed, content=<a href='/topic/show?id=53f24521227' target=_blank style='color:#2F92EE;'>#子宫颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45212, encryptionId=53f24521227, topicName=子宫颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407883, encodeId=b6ac140e883e9, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540857, encodeId=fd3c154085e10, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 yxch36
  6. [GetPortalCommentsPageByObjectIdResponse(id=1967350, encodeId=8bbc196e35042, content=<a href='/topic/show?id=56094228264' target=_blank style='color:#2F92EE;'>#增强子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42282, encryptionId=56094228264, topicName=增强子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Mar 01 02:45:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006679, encodeId=7d0920066e902, content=<a href='/topic/show?id=199d452095f' target=_blank style='color:#2F92EE;'>#子宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45209, encryptionId=199d452095f, topicName=子宫颈)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKjqGDO7icVKUiaT7urgwXvnvzWtp0fMFU46Xfib8oavFKygiaWtibXReS6ZUh3PImsNicGAwTO5HXxoicnA/132, createdBy=ee262500130, createdName=ms7474195563676018, createdTime=Mon Apr 30 06:45:00 CST 2012, time=2012-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789396, encodeId=08af1e89396c0, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Oct 01 23:45:00 CST 2012, time=2012-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701014, encodeId=1e2f1e010148b, content=<a href='/topic/show?id=7113e15237a' target=_blank style='color:#2F92EE;'>#癌细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71523, encryptionId=7113e15237a, topicName=癌细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb930318282, createdName=hywen7336, createdTime=Sat Jan 19 09:45:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251865, encodeId=31231251865d0, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282855, encodeId=404d1282855ed, content=<a href='/topic/show?id=53f24521227' target=_blank style='color:#2F92EE;'>#子宫颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45212, encryptionId=53f24521227, topicName=子宫颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407883, encodeId=b6ac140e883e9, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540857, encodeId=fd3c154085e10, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1967350, encodeId=8bbc196e35042, content=<a href='/topic/show?id=56094228264' target=_blank style='color:#2F92EE;'>#增强子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42282, encryptionId=56094228264, topicName=增强子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Mar 01 02:45:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006679, encodeId=7d0920066e902, content=<a href='/topic/show?id=199d452095f' target=_blank style='color:#2F92EE;'>#子宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45209, encryptionId=199d452095f, topicName=子宫颈)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKjqGDO7icVKUiaT7urgwXvnvzWtp0fMFU46Xfib8oavFKygiaWtibXReS6ZUh3PImsNicGAwTO5HXxoicnA/132, createdBy=ee262500130, createdName=ms7474195563676018, createdTime=Mon Apr 30 06:45:00 CST 2012, time=2012-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789396, encodeId=08af1e89396c0, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Oct 01 23:45:00 CST 2012, time=2012-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701014, encodeId=1e2f1e010148b, content=<a href='/topic/show?id=7113e15237a' target=_blank style='color:#2F92EE;'>#癌细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71523, encryptionId=7113e15237a, topicName=癌细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb930318282, createdName=hywen7336, createdTime=Sat Jan 19 09:45:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251865, encodeId=31231251865d0, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282855, encodeId=404d1282855ed, content=<a href='/topic/show?id=53f24521227' target=_blank style='color:#2F92EE;'>#子宫颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45212, encryptionId=53f24521227, topicName=子宫颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407883, encodeId=b6ac140e883e9, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540857, encodeId=fd3c154085e10, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]
    2012-04-12 一闲
  8. [GetPortalCommentsPageByObjectIdResponse(id=1967350, encodeId=8bbc196e35042, content=<a href='/topic/show?id=56094228264' target=_blank style='color:#2F92EE;'>#增强子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42282, encryptionId=56094228264, topicName=增强子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Fri Mar 01 02:45:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006679, encodeId=7d0920066e902, content=<a href='/topic/show?id=199d452095f' target=_blank style='color:#2F92EE;'>#子宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45209, encryptionId=199d452095f, topicName=子宫颈)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKjqGDO7icVKUiaT7urgwXvnvzWtp0fMFU46Xfib8oavFKygiaWtibXReS6ZUh3PImsNicGAwTO5HXxoicnA/132, createdBy=ee262500130, createdName=ms7474195563676018, createdTime=Mon Apr 30 06:45:00 CST 2012, time=2012-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1789396, encodeId=08af1e89396c0, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Mon Oct 01 23:45:00 CST 2012, time=2012-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1701014, encodeId=1e2f1e010148b, content=<a href='/topic/show?id=7113e15237a' target=_blank style='color:#2F92EE;'>#癌细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71523, encryptionId=7113e15237a, topicName=癌细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fb930318282, createdName=hywen7336, createdTime=Sat Jan 19 09:45:00 CST 2013, time=2013-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251865, encodeId=31231251865d0, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282855, encodeId=404d1282855ed, content=<a href='/topic/show?id=53f24521227' target=_blank style='color:#2F92EE;'>#子宫颈癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45212, encryptionId=53f24521227, topicName=子宫颈癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1407883, encodeId=b6ac140e883e9, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1540857, encodeId=fd3c154085e10, content=<a href='/topic/show?id=ba2ee78630b' target=_blank style='color:#2F92EE;'>#细胞增殖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77863, encryptionId=ba2ee78630b, topicName=细胞增殖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f58613291856, createdName=晓辰, createdTime=Thu Apr 12 14:45:00 CST 2012, time=2012-04-12, status=1, ipAttribution=)]

相关资讯

J. Exp. Med.:阻断CDK蛋白可导致三阴性乳腺癌萎缩

根据PDB文件1nkp而构建出c-Myc(红色)与Max(蓝色)和DNA形成的复合物的结构。图片来自维基共享资源。 根据2012年3月9日发表在Journal of Experimental Medicine期刊上的一篇研究论文,抑制一种大量存在的促进生长的蛋白能够导致三阴性乳腺癌消退。 三阴性乳腺癌(triple-negative breast tumor)缺乏其他类型乳腺癌中存在的所有已知

Cell Reports:科学家破解癌细胞耐受药物MLN4924秘密

基于PDB文件1ndd利用PyMOL渲染构建NEDD8蛋白结构图,图片来自维基共享资源。 【Copyright ©版权Bioon.com所有,若未得到生物谷授权,请勿转载。】 对癌症患者而言,耐药性是一个严重性问题:药物治疗刚开始有一些疗效,但是过一段时间之后,不能发挥作用。如今,来自美国桑福德-伯纳姆医学研究所(Sanford-Burnham Medical Research In

Nat Biotechnol:治疗皮肤癌的黑色素瘤疫苗研究获新突破

梅奥诊所研究人员将人黑色素瘤细胞的DNA与一种狂犬病病毒进行基因组合后,提高老鼠的免疫系统功能进而根除皮肤癌。这种战略称为癌症的免疫疗法,即采用基因工程改造过的水泡性口炎病毒直接将黑色素瘤细胞来源的广谱基因传递带肿瘤内。在早期的研究中,60%的荷瘤小鼠在不到3个月的时间内就得到治愈,并且副作用也很少。 最新研究结果发表在本周的《自然生物技术》杂志上。 梅奥诊所分子医学系研究人员、文章合著者

EMBO Mol Med:鉴定癌症类型的新技术

犹他州大学Huntsman癌症研究所的研究人员称他们已经发现了一种快速、准确且成本低廉的方法来确定引发癌症的遗传物质的重组即染色体易位情况。有关该方法的描述和研究结果发表在EMBO Molecular Medicine杂志上。 许多癌症类型是由肿瘤细胞中染色体易位导致的。虽然已发现数百种引发癌症的染色体易位,但目前检测方法有重大缺陷。 犹他州大学Huntsman癌症研究所主任Stephen

PLoS One:发现调节前列腺癌发展的miRNA以及治疗药物

去势抵抗性前列腺癌 (CRPC) 的发生促进了前列腺癌(PCa)病人的高死亡率,这在某种程度上归因于肿瘤干细胞(CSCs)的存在及出现。近期来自美国韦恩州立大学医学院的Fazlul H. Sarkar等人研究表明,解除对Let-7(一种miRNAs)表达的控制会促进PCa的发生和发展,并且这个过程能够被BR-DIM所改变。相关研究发表在3月19日美国《公共科学图书馆·综合(PLoS One)上。

FEBS Letters:癌症抑制相关因子RBM5有效促进DHX15解旋酶活性

2012年3月17日,北京生命科学研究所李夏璐研究小组在《FEBS Letters》杂志在线发表文章,报道了癌症抑制因子RBM5与剪接因子DHX15直接相互作用,从而提高了DHX15核酸解旋酶的活性。 在肺癌等多种癌症发生早期,都伴随有染色体3p21.3区域的缺失,RBM5基因则位于这段区域内。前期研究发现,RBM5的高表达能促进细胞凋亡,低表达则诱导细胞癌化。因此,RBM5一直以来被认为是癌症

Baidu
map
Baidu
map
Baidu
map